Aeglea Biotherapeutics shares owned by Meeder Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Meeder Asset Management
from 13F filings
Historical chart of Meeder Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Meeder Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $5.9k | 181 | 32.76 |
| 2025-09-30 | $3.6k | 216 | 16.76 |
| 2025-06-30 | $2.5k | 170 | 14.97 |